Janssen Pharmaceuticals, Inc. agreed to acquire Assets of MeiraGTx Holdings plc from MeiraGTx Holdings plc (NasdaqGS:MGTX) for approximately $130 million on December 21, 2023. As part of consideration $65 million will pay at signing, an additional $50 million anticipated in the first quarter of 2024, with the remaining $15 million in milestone payments expected later in 2024. Evercore Group L.L.C. acted as financial advisor to MeiraGTx Holdings plc (NasdaqGS:MGTX) and Morgan, Lewis & Bockius LLP acted as legal advisor to MeiraGTx Holdings plc (NasdaqGS:MGTX).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.91 USD | +2.29% | -2.19% | -30.06% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.06% | 309M | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- MGTX Stock
- News MeiraGTx Holdings plc
- Janssen Pharmaceuticals, Inc. agreed to acquire Assets of MeiraGTx Holdings plc from MeiraGTx Holdings plc for approximately $130 million.